Related Experiment Video
Updated: Aug 6, 2026

Building Up Skin Models for Numerous Applications - from Two-Dimensional (2D) Monoculture to Three-Dimensional (3D) Multiculture
Published on: October 20, 2023
Next-Generation Risk Assessment for cosmetic ingredients: a critical evaluation of published case studies
Rahul Upadhyay Nepal1,2, Seok Kwon3, Kyu-Bong Kim1,2
1Department of Pharmacy, College of Pharmacy, Dankook University, Cheonan, Republic of Korea.
Next Generation Risk Assessment (NGRA) successfully identifies safe cosmetic ingredients using new approach methodologies (NAMs). While effective for some endpoints, further research is needed for complex toxicological assessments to fully replace animal testing.
Area of Science:
- Toxicology
- Risk Assessment
- Cosmetic Science
Background:
- Animal testing for cosmetic safety is under increasing regulatory and scientific pressure.
- Next Generation Risk Assessment (NGRA) provides a human-centric framework utilizing new approach methodologies (NAMs).
Purpose of the Study:
- To critically evaluate the current state of NGRA in cosmetic safety assessments.
- To analyze case studies demonstrating NGRA's application across various toxicological endpoints.
Main Methods:
- Review of 9 published case studies involving 7 chemicals.
- Analysis of NGRA components: physiologically based kinetic (PBK) modeling, adverse outcome pathways (AOPs), integrated approaches to testing and assessment (IATA), and threshold of toxicological concern (TTC).
- Evaluation of defined approaches for skin sensitization and other endpoints.
Main Results:
- NGRA successfully identified safe concentrations for cosmetic ingredients, meeting regulatory safety margins.
- Defined approaches for skin sensitization and eye irritation have achieved regulatory acceptance.
- Significant gaps remain in validated NGRA frameworks for complex systemic toxicity endpoints.
Conclusions:
- NGRA demonstrates potential as a robust, ethical alternative to animal testing in cosmetic safety.
- Advancements require integrating metabolically competent models, AI, multi-organ micro-physiological systems, and standardized interpretation frameworks.
- A roadmap is provided for strengthening NGRA for comprehensive human health risk assessment.
More Related Videos
06:30Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
Published on: May 17, 2021
10:13Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model
Published on: August 23, 2015
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mutagenicity and Carcinogenicity
Toxicity Testing in Animals
Preclinical Development: Overview